Anjali S. Vekaria

Baseline IL-22 expression in patients with atopic dermatitis stratifies tissue responses to fezakinumab

Patrick M. Brunner, Ana B. Pavel, Saakshi Khattri et al. · Journal of Allergy and Clinical Immunology · 2018 · 197 citations · Full text

Medicine, Dermatology, Immunology +14

A randomized placebo-controlled single-center pilot study of the safety and efficacy of apremilast in subjects with moderate-to-severe alopecia areata

Daniela Mikhaylov, Ana B. Pavel, Christopher J. Yao et al. · Archives of Dermatological Research · 2018 · 60 citations

Medicine, Dermatology, Pharmacotherapy +10

Moderate-to-severe atopic dermatitis patients show increases in serum C-reactive protein levels, correlating with skin disease activity

Anjali S. Vekaria, Patrick M. Brunner, Ahmad Aleisa et al. · F1000Research · 2017 · 51 citations · Full text

Medicine, Dermatology, Immunology +17

Effective use of ustekinumab in a patient with concomitant psoriasis, vitiligo, and alopecia areata

Amal Elkady, Yasmin Amir, Anjali S. Vekaria et al. · JAAD Case Reports · 2017 · 37 citations · Full text

Medicine, Dermatology, Pharmacotherapy +15

Atopic dermatitis patients show increases in serum C-reactive protein levels, correlating with skin disease activity

Anjali S. Vekaria, Patrick M. Brunner, Ahmad Aleisa et al. · F1000Research · 2017 · 19 citations · Full text

Medicine, Dermatology, Immunology +17